Skip to content
Trial Eligibility
Menu

EyeConic: Qualification for Cone-Optogenetics

NCT05294978

This study is recruiting at 3 US sites in 3 states, according to its ClinicalTrials.gov record last updated .

Summary

This study aims to prepare for the first-in-human clinical trial of cone optogenetics vision restoration. As a first step, this worldwide multicenter ocular imaging study (EyeConic Study) is performed to identify eligible patients.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Retinal Dystrophies

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
Any age
Sex
All
Healthy volunteers
Accepted
Sponsor
Institute of Molecular and Clinical Ophthalmology Basel
Last updated on ClinicalTrials.gov
July 31, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • University of California San Francisco, Department of Ophthalmology · San Francisco, CA

Florida · 1

  • Bascom Palmer Eye Institute · Miami, FL

Pennsylvania · 1

  • University of Pittsburgh, Department of Ophthalmology · Pittsburgh, PA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.